Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation
Petr Kala(Masaryk University), Miloš Táborský(Na Homolce Hospital), John D. Imig(University of Arkansas for Medical Sciences), Šárka Jíchová(Institute of Clinical and Experimental Medicine), Marek Vícha(University Hospital Olomouc), Luděk Červenka(České Energetické Závody (Czechia)), Matúš Miklovič(Charles University), Petra Škaroupková(Institute of Clinical and Experimental Medicine), Renata Aiglová(University Hospital Olomouc), John R. Falck(The University of Texas Southwestern Medical Center), Olga Gawryś(Institute of Clinical and Experimental Medicine), Vít Gloger(University Hospital Olomouc), Hana Maxová(Charles University), Janusz Sadowski(Polish Academy of Sciences), Elżbieta Kompanowska‐Jezierska(Polish Academy of Sciences), Zdeňka Vaňourková(Institute of Clinical and Experimental Medicine), Josef Veselka(Universitat Autònoma de Barcelona)
Cited by 22
Related Papers
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
|Journal of Clinical Investigation|2011|292
The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association
|European Heart Journal|2014|211
Long‐term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS
|Catheterization and Cardiovascular Interventions|2009|190
Epoxyeicosanoids promote organ and tissue regeneration
|Proceedings of the National Academy of Sciences|2013|153